Aikou Okamoto

48PUBLICATIONS
294CO-AUTHORS
Molecular targetsPredictive and prognostic markersGeriatrics and gerontologyOncology and carcinogenesis not elsewhere classifiedHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Sep 26, 2026
Guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer: 2025 edition by the Japan Society of Gynecologic Oncology.

|Sep 17, 2026
Changes and clinical impact of HER3 and ERBB3 expression in primary and recurrent ovarian cancer.

|Aug 07, 2026
Real-world safety and effectiveness of olaparib maintenance after first-relapse platinum-sensitive ovarian cancer in Japan: a multicenter historical cohort (JGOG3026).

|Jul 25, 2026
Outcome of advanced ovarian cancer patients who do not undergo cytoreductive surgery in the era of PARP inhibitors maintenance therapy: a propensity score-based analysis.

|Jun 19, 2026
Nationwide survey of hereditary breast and ovarian cancer-related clinical practice in gynecologic oncology in Japan: a joint study by the Japan Society of Gynecologic Oncology (JSGO) and the Japan Society of Obstetrics and Gynecology (JSOG).

|Feb 07, 2026
Long-term chemotherapy-induced peripheral neuropathy evaluated using patient-reported outcomes in gynecologic malignancies.

Chikage Narui, Hiroshi Tanabe, Masataka Takenaka

Pageof 8

Frequent Collaborators

11 joint publications

Hiroshi Tanabe

10 joint publications

Takayuki Enomoto

10 joint publications

Kazuhiro Takehara

10 joint publications

Hirokuni Takano